# A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)

> **NCT00777608** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 106 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Comparator: Placebo 5mg (run in)
- **DRUG:** Donepezil 5 - 10 mg
- **DRUG:** Comparator: Placebo 5-10 mg
- **DRUG:** Donepezil 10 mg

## Key facts

- **NCT ID:** NCT00777608
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-10
- **Final completion:** 2010-04
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2015-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777608, "A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00777608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*